All lobbying filings

WILLIS NORTH AMERICA INC.

WILLIS NORTH AMERICA INC. filed a Q1 report for WILLIS NORTH AMERICA INC. on April 21, 2025.

Lobbying for WILLIS NORTH AMERICA INC.

All filings by WILLIS NORTH AMERICA INC. · Everything WILLIS NORTH AMERICA INC. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$50,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New York

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Health Issues

Issues related to the implementation of the Patient Protection and Affordable Care Act (PL 111-148). Issues related to Health Reimbursement Arrangements.

Budget/Appropriations

Issues related to the implementation of the Consolidated Appropriations Act (PL 117-328).

Medicare/Medicaid

Proposed Rule CMS-4205-P: Issues related to Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program and Medicare Prescription Drug Program.

Retirement

Issues related to pooled employer plans in draft legislation to amend the Internal Revenue Code of 1986 and the Employee Retirement Income Security Act of 1974 to make technical corrections relating to the SECURE 2.0 Act of 2022 (PUBLIC LAW 117-328).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.